SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the September 2024 quarter is pegged at Rs. 16326.70 millions, about 9.27% up against Rs. 14941.40 millions recorded during the year-ago period.A humble growth in net profit of 14.59% reported in the quarter ended September 2024 to Rs. 3586.10  millions from Rs. 3129.40 millions.OP of the company witnessed a marginal growth to 4994.40 millions from 4363.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 16326.70 14941.40 9.27 31902.80 29731.40 7.30 58489.10 53487.30 9.35
Other Income 604.80 555.10 8.95 1278.10 1115.10 14.62 2482.70 1541.50 61.06
PBIDT 4994.40 4363.90 14.45 9577.80 8473.90 13.03 17013.70 13597.80 25.12
Interest 25.00 31.30 -20.13 52.50 64.70 -18.86 124.50 159.90 -22.14
PBDT 4969.40 4332.60 14.70 9525.30 8409.20 13.27 16889.20 13437.90 25.68
Depreciation 175.10 178.40 -1.85 358.80 350.10 2.49 711.70 699.70 1.72
PBT 4794.30 4154.20 15.41 9166.50 8059.10 13.74 16177.50 12738.20 27.00
TAX 1208.20 1024.80 17.90 2300.30 2027.30 13.47 4165.30 3244.10 28.40
Deferred Tax -2.10 -18.00 -88.33 -23.70 -35.60 -33.43 10.70 -11.90 -189.92
PAT 3586.10 3129.40 14.59 6866.20 6031.80 13.83 12012.20 9494.10 26.52
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 30.59 29.21 4.74 30.02 28.50 5.33 29.09 25.42 14.42

Abbott India Share Price

25470.15 -108.75 (-0.43%)
21-Apr-2026 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.45
Dr. Reddys Lab 1221.90
Cipla 1230.50
Zydus Lifesciences 930.90
Lupin 2323.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×